Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 10.4088 | 98 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 9.75794 | 98 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 10.4853 | 98 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 9.50451 | 97 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 10.6761 | 98 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 10.416 | 98 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 10.4075 | 98 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 11.4246 | 99 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 11.2013 | 99 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 10.5683 | 98 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 9.9053 | 98 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 10.1456 | 98 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 10.8334 | 99 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 10.3565 | 98 |